Safilo Group S.p.A. (BIT:SFL)
Italy · Delayed Price · Currency is EUR 1.690
+0.004 (0.24%)
Mar 27, 2026, 5:35 PM CET
Safilo Group Revenue
In the year 2025, Safilo Group had annual revenue of 983.38M EUR, down -0.99%. Safilo Group had revenue of 445.75M in the half year ending December 31, 2025, a decrease of -6.08%.
Revenue
983.38M
Revenue Growth
-0.99%
P/S Ratio
0.71
Revenue / Employee
285.12K
Employees
3,449
Market Cap
698.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 983.38M | -9.84M | -0.99% |
| Dec 31, 2024 | 993.22M | -31.51M | -3.08% |
| Dec 31, 2023 | 1.02B | -52.01M | -4.83% |
| Dec 31, 2022 | 1.08B | 107.16M | 11.05% |
| Dec 31, 2021 | 969.58M | 189.29M | 24.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| Amplifon | 2.40B |
| DiaSorin | 1.20B |
| EL.En. | 590.85M |
| GPI S.p.A. | 531.42M |
| Garofalo Health Care | 487.08M |
| Svas Biosana | 134.95M |
| Pharmanutra | 133.97M |
Safilo Group News
- 15 days ago - Safilo Group S.p.A. (SAFLY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Safilo Group S.p.A. (SAFLY) Q3 2025 Sales Call Transcript - Seeking Alpha